연구동향
기준 논문: Adverse Events With Sustained-Release Donepezil in Alzheimer Disease: Relation to Body Mass Index
이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.
1,142편 검색→1,077편 판독→302편 선별 (관련도 0.5 이상)
질문과 PubMed 검색식 보기
질문: Donepezil adverse events in Alzheimer disease
(donepezil[tiab] OR Aricept[tiab]) AND (adverse[tiab] OR side effect*[tiab] OR toxicity[tiab] OR safety[tiab]) AND (Alzheimer*[tiab] OR dementia[tiab])출판 연도
선별된 302편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.
주제별 논문
주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.
01double-blind · trial93편
- 0.96
Hong YJ, Han HJ, Youn YC et al. · Alzheimer's research & therapy · 2019
- 0.96
Tariot P, Salloway S, Yardley J et al. · BMC research notes · 2012
- 0.95
Donepezil: tolerability and safety in Alzheimer's disease
Pratt RD, Perdomo CA, Surick IW et al. · International journal of clinical practice · 2002
- 0.95
Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease
Jia J, Wei C, Chen W et al. · Journal of Alzheimer's disease : JAD · 2020
- 0.95
Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
Farlow M, Veloso F, Moline M et al. · BMC neurology · 2011
- 0.95
Hong YJ, Han HJ, Youn YC et al. · Dementia and geriatric cognitive disorders · 2021
- 0.94
Burns A, Gauthier S, Perdomo C · International journal of geriatric psychiatry · 2007
- 0.94
Rogers SL, Farlow MR, Doody RS et al. · Neurology · 1998
- 0.94
A large, community-based, open-label trial of donepezil in the treatment of Alzheimer's disease
Relkin NR, Reichman WE, Orazem J et al. · Dementia and geriatric cognitive disorders · 2003
- 0.94
Doody RS, Geldmacher DS, Farlow MR et al. · Dementia and geriatric cognitive disorders · 2012
- 0.94
Wilkinson DG, Passmore AP, Bullock R et al. · International journal of clinical practice · 2002
- 0.94
Doody RS, Geldmacher DS, Gordon B et al. · Archives of neurology · 2001
- 0.93
Homma A, Takeda M, Imai Y et al. · Dementia and geriatric cognitive disorders · 2000
- 0.93
Safety and efficacy of donepezil in African Americans with mild-to-moderate Alzheimer's disease
Griffith P, Lichtenberg P, Goldman R et al. · Journal of the National Medical Association · 2006
- 0.93
Donepezil therapy in clinical practice: a randomized crossover study
Greenberg SM, Tennis MK, Brown LB et al. · Archives of neurology · 2000
- 0.93
Farlow MR, Salloway S, Tariot PN et al. · Clinical therapeutics · 2010
- 0.93
Doody RS, Corey-Bloom J, Zhang R et al. · Drugs & aging · 2008
- 0.92
Rogers SL, Doody RS, Pratt RD et al. · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2000
- 0.92
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
Winblad B, Engedal K, Soininen H et al. · Neurology · 2001
- 0.92
Rogers SL, Doody RS, Mohs RC et al. · Archives of internal medicine · 1998
- 0.92
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
Feldman H, Gauthier S, Hecker J et al. · Neurology · 2001
- 0.92
Donepezil 23 mg in Asian patients with moderate-to-severe Alzheimer's disease
Han SH, Lee JH, Kim SY et al. · Acta neurologica Scandinavica · 2017
- 0.92
Tariot PN, Cummings JL, Katz IR et al. · Journal of the American Geriatrics Society · 2001
- 0.92
Boada-Rovira M, Brodaty H, Cras P et al. · Drugs & aging · 2004
- 0.92
Rogers SL, Friedhoff LT · Dementia (Basel, Switzerland) · 1996
- 0.91
Rogers SL, Friedhoff LT · European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 1998
- 0.91
Jia J, Wei C, Jia L et al. · Journal of Alzheimer's disease : JAD · 2017
- 0.91
Homma A, Atarashi H, Kubota N et al. · Journal of Alzheimer's disease : JAD · 2016
- 0.90
Salloway S, Mintzer J, Cummings JL et al. · American journal of Alzheimer's disease and other dementias · 2012
- 0.90
Ridha BH, Crutch S, Cutler D et al. · Alzheimer's research & therapy · 2018
- 0.90
Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease
Chase TN, Farlow MR, Clarence-Smith K · Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017
- 0.90
Homma A, Imai Y, Tago H et al. · Dementia and geriatric cognitive disorders · 2009
- 0.90
Winblad B, Kilander L, Eriksson S et al. · Lancet (London, England) · 2006
- 0.90
Bullock R, Touchon J, Bergman H et al. · Current medical research and opinion · 2005
- 0.90
3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy
Winblad B, Wimo A, Engedal K et al. · Dementia and geriatric cognitive disorders · 2006
- 0.89
Nakamura Y, Kim R, Nishiyama K et al. · Geriatrics & gerontology international · 2023
- 0.88
Jones RW, Soininen H, Hager K et al. · International journal of geriatric psychiatry · 2004
- 0.88
Gauthier S, Feldman H, Hecker J et al. · Current medical research and opinion · 2002
- 0.87
Prasher VP, Huxley A, Haque MS · International journal of geriatric psychiatry · 2002
- 0.87
Han HJ, Park MY, Park KW et al. · Journal of clinical neurology (Seoul, Korea) · 2022
- 0.86
Akhondzadeh S, Shafiee Sabet M, Harirchian MH et al. · Psychopharmacology · 2010
- 0.86
Donepezil preserves cognition and global function in patients with severe Alzheimer disease
Black SE, Doody R, Li H et al. · Neurology · 2007
- 0.86
Froelich L, Gertz HJ, Heun R et al. · Dementia and geriatric cognitive disorders · 2004
- 0.85
Donepezil in the treatment of Alzheimer's disease: long-term efficacy and safety
Rocca P, Cocuzza E, Marchiaro L et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2002
- 0.83
Santens P, Ventura M · Acta neurologica Belgica · 2003
- 0.83
The effects of donepezil in Alzheimer's disease - results from a multinational trial
Burns A, Rossor M, Hecker J et al. · Dementia and geriatric cognitive disorders · 1999
- 0.82
Zhang Z, Yu L, Gaudig M et al. · Neuropsychiatric disease and treatment · 2012
- 0.82
Sadowsky CH, Farlow MR, Atkinson L et al. · Primary care companion to the Journal of clinical psychiatry · 2005
- 0.81
Knopman DS · The international journal of neuropsychopharmacology · 2000
- 0.81
Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials
Winblad B, Black SE, Homma A et al. · Current medical research and opinion · 2009
- 0.78
Safety and tolerability of donepezil in mild cognitive impairment: open-label extension study
Doody RS, Ferris S, Salloway S et al. · American journal of Alzheimer's disease and other dementias · 2010
- 0.78
Acupuncture as an adjunct therapy for mild Alzheimer's disease: A randomized clinical trial
Kong X, Han R, Fan X et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.77
Ancoli-Israel S, Amatniek J, Ascher S et al. · Alzheimer disease and associated disorders · 2005
- 0.76
Courtney C, Farrell D, Gray R et al. · Lancet (London, England) · 2004
- 0.74
Alvarez XA, Cacabelos R, Sampedro C et al. · Current Alzheimer research · 2011
- 0.74
Finkel SI, Mintzer JE, Dysken M et al. · International journal of geriatric psychiatry · 2004
- 0.74
Acupuncture for patients with mild to moderate Alzheimer's disease: a randomized controlled trial
Jia Y, Zhang X, Yu J et al. · BMC complementary and alternative medicine · 2017
- 0.74
Atri A, Molinuevo JL, Lemming O et al. · Alzheimer's research & therapy · 2013
- 0.74
Bryson HM, Benfield P · Drugs & aging · 1997
- 0.73
Donepezil 23 mg: An empty suit
Knopman DS · Neurology. Clinical practice · 2012
- 0.73
Hong YJ, Choi SH, Jeong JH et al. · Journal of Alzheimer's disease : JAD · 2018
- 0.72
Tian J, Shi J, Li T et al. · Evidence-based complementary and alternative medicine : eCAM · 2017
- 0.70
Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial
Doody RS, Ferris SH, Salloway S et al. · Neurology · 2009
- 0.69
Whitehead A, Perdomo C, Pratt RD et al. · International journal of geriatric psychiatry · 2004
- 0.69
Gauthier S, Rountree S, Finn B et al. · Journal of Alzheimer's disease : JAD · 2015
- 0.68
Pakdaman H, Harandi AA, Hatamian H et al. · Dementia and geriatric cognitive disorders extra · 2015
- 0.68
Chen Z, Zhang H, Guo Y et al. · NPJ digital medicine · 2021
- 0.68
Roman GC, Salloway S, Black SE et al. · Stroke · 2010
- 0.67
Shim Y, Han HJ, Park KW et al. · Journal of Alzheimer's disease : JAD · 2022
- 0.66
Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial
Seltzer B, Zolnouni P, Nunez M et al. · Archives of neurology · 2004
- 0.66
Tariot PN, Farlow MR, Grossberg GT et al. · JAMA · 2004
- 0.66
Gault LM, Lenz RA, Ritchie CW et al. · Alzheimer's research & therapy · 2016
- 0.65
Perspectives in the management of Alzheimer's disease: clinical profile of donepezil
Rogers SL · Dementia and geriatric cognitive disorders · 1998
- 0.65
Sadowsky CH, Dengiz A, Meng X et al. · Primary care companion to the Journal of clinical psychiatry · 2010
- 0.64
Feldman H, Gauthier S, Hecker J et al. · International journal of geriatric psychiatry · 2005
- 0.63
Kwon JC, Kim EG, Kim JW et al. · American journal of Alzheimer's disease and other dementias · 2009
- 0.62
Devanand DP, Pelton GH, D'Antonio K et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2018
- 0.60
Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial
Salloway S, Ferris S, Kluger A et al. · Neurology · 2004
- 0.58
Two randomized controlled trials of SB742457 in mild-to-moderate Alzheimer's disease
Maher-Edwards G, Watson C, Ascher J et al. · Alzheimer's & dementia (New York, N. Y.) · 2015
- 0.58
Reynolds CF3, Butters MA, Lopez O et al. · Archives of general psychiatry · 2011
- 0.56
Fullerton T, Binneman B, David W et al. · Alzheimer's research & therapy · 2018
- 0.56
Donepezil in vascular dementia: a randomized, placebo-controlled study
Wilkinson D, Doody R, Helme R et al. · Neurology · 2003
- 0.56
Frolich L, Atri A, Ballard C et al. · Journal of Alzheimer's disease : JAD · 2019
- 0.56
Black S, Roman GC, Geldmacher DS et al. · Stroke · 2003
- 0.55
Yokoyama S, Yoshinaga T, Matsuzaki J et al. · Journal of Alzheimer's disease : JAD · 2019
- 0.55
Efficacy and safety evaluation of HSD-1 inhibitor ABT-384 in Alzheimer's disease
Marek GJ, Katz DA, Meier A et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2014
- 0.54
Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial
Shi J, Wei M, Ni J et al. · Journal of translational medicine · 2020
- 0.52
Figiel GS, Sadowsky CH, Strigas J et al. · Primary care companion to the Journal of clinical psychiatry · 2008
- 0.52
Lang FM, Mo Y, Sabbagh M et al. · Alzheimer's & dementia (New York, N. Y.) · 2021
- 0.52
A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer's dementia
Haig GM, Pritchett Y, Meier A et al. · Journal of Alzheimer's disease : JAD · 2014
- 0.52
Prabhakar S, Vishnu VY, Modi M et al. · Annals of Indian Academy of Neurology · 2020
- 0.51
Passmore AP, Bayer AJ, Steinhagen-Thiessen E · Journal of the neurological sciences · 2005
- 0.50
Nirogi R, Ieni J, Goyal VK et al. · Alzheimer's & dementia (New York, N. Y.) · 2022
02state examination · mini-mental79편
- 0.94
Safety and effectiveness of donepezil on behavioral symptoms in patients with Alzheimer disease
Carrasco MM, Aguera L, Gil P et al. · Alzheimer disease and associated disorders · 2011
- 0.92
Hager K, Calabrese P, Frolich L et al. · Dementia and geriatric cognitive disorders · 2003
- 0.91
Efficacy and safety of donepezil in patients with Alzheimer's disease in assisted living facilities
Rosenblatt A, Gao J, Mackell J et al. · American journal of Alzheimer's disease and other dementias · 2010
- 0.91
Mehta S, Chandersekhar K, Prasadrao G et al. · Indian journal of psychiatry · 2012
- 0.91
Lopez OL, Mackell JA, Sun Y et al. · Journal of the National Medical Association · 2008
- 0.91
Tu H, Zhou S, Lin J · British journal of hospital medicine (London, England : 2005) · 2025
- 0.91
Kim TE, Bae JW, Hong S et al. · The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2025
- 0.91
Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan
Nozawa M, Ichimiya Y, Nozawa E et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2009
- 0.90
Treatment with donepezil in Alzheimer patients with and without cerebrovascular disease
Frolich L, Klinger T, Berger FM · Journal of the neurological sciences · 2002
- 0.90
Klinger T, Ibach B, Schoenknecht P et al. · Current medical research and opinion · 2005
- 0.89
Yatabe Y, Hashimoto M, Kaneda K et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2013
- 0.89
Mossello E, Tonon E, Caleri V et al. · Archives of gerontology and geriatrics. Supplement · 2004
- 0.89
Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia
Park KH, Yang Y, Chen C et al. · Journal of clinical neurology (Seoul, Korea) · 2021
- 0.89
Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic
Matthews HP, Korbey J, Wilkinson DG et al. · International journal of geriatric psychiatry · 2000
- 0.87
Donepezil for the treatment of behavioral symptoms in patients with Alzheimer's disease
Paleacu D, Mazeh D, Mirecki I et al. · Clinical neuropharmacology · 2002
- 0.87
Sakka P, Tsolaki M, Hort J et al. · Current medical research and opinion · 2007
- 0.86
Arai H, Hashimoto N, Sumitomo K et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2018
- 0.86
Kim JM, Shin IS, Yoon JS · International psychogeriatrics · 2002
- 0.86
Li Dq, Zhou Yp, Yang H · International journal of medical sciences · 2012
- 0.86
Rapp M, Burkart M, Kohlmann T et al. · International journal of clinical pharmacology and therapeutics · 2018
- 0.85
Sakakibara R, Uchiyama T, Yoshiyama M et al. · Neurourology and urodynamics · 2005
- 0.84
Fischer MHF, Zibrandtsen IC, Johannsen P et al. · Journal of Alzheimer's disease reports · 2024
- 0.83
Yancheva S, Ihl R, Nikolova G et al. · Aging & mental health · 2009
- 0.83
Kheirkhah F, Hamzehkolaee ME, Parvizi S et al. · Naunyn-Schmiedeberg's archives of pharmacology · 2026
- 0.82
Abbas Raja A, Amjad A, Choudhary A et al. · Cureus · 2025
- 0.82
Yang H, Han W, Li H · Pakistan journal of pharmaceutical sciences · 2020
- 0.82
Deng X, Zeng Y, Ding D · Pakistan journal of pharmaceutical sciences · 2026
- 0.82
Arai H, Sumitomo K, Sakata Y et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2016
- 0.81
Ma SL, Tang NLS, Wat KHY et al. · American journal of Alzheimer's disease and other dementias · 2019
- 0.81
Touchon J, Bergman H, Bullock R et al. · Current medical research and opinion · 2006
- 0.79
Wang J, Guo X, Lu W et al. · Journal of Alzheimer's disease : JAD · 2021
- 0.79
Wang J, Yang S, Hu Z et al. · Pakistan journal of pharmaceutical sciences · 2019
- 0.79
Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease
Bullock R, Bergman H, Touchon J et al. · Current medical research and opinion · 2006
- 0.78
Kamei T, Kobayashi H, Nishida M et al. · Patient preference and adherence · 2021
- 0.78
A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease
Wilcock G, Howe I, Coles H et al. · Drugs & aging · 2003
- 0.78
Ma Y, Ji J, Li G et al. · Experimental and therapeutic medicine · 2018
- 0.76
Blesa R, Bullock R, He Y et al. · Pharmacogenetics and genomics · 2006
- 0.76
Cumbo E, Ligori LD · Journal of Alzheimer's disease : JAD · 2014
- 0.76
Pharmacokinetic and safety assessments of concurrent administration of risperidone and donepezil
Zhao Q, Xie C, Pesco-Koplowitz L et al. · Journal of clinical pharmacology · 2003
- 0.76
Therapeutic Potential of Jiedu Yizhi Formula for Alzheimer's Disease: A Randomized Controlled Trial
Li YQ, Chen DX, Zhu XT et al. · Chinese journal of integrative medicine · 2026
- 0.76
Xu M, Yue Y, Huang J · Journal of pharmaceutical and biomedical analysis · 2023
- 0.75
Miao Yc, Tian Jz, Shi J et al. · Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine · 2012
- 0.75
Fang X, Zhang J, Zhao J et al. · Journal of healthcare engineering · 2022
- 0.75
Yang X, Chen Q · Experimental and therapeutic medicine · 2021
- 0.74
Bago Rozankovic P, Rozankovic M, Badzak J et al. · Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology · 2021
- 0.73
Gareri P, Putignano D, Castagna A et al. · Journal of Alzheimer's disease : JAD · 2014
- 0.73
Zheng W, Sun X, Liu J · Evidence-based complementary and alternative medicine : eCAM · 2022
- 0.71
Kanaya K, Abe S, Sakai M et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2012
- 0.71
Yang Y, Liu JP, Fang JY et al. · Chinese journal of integrative medicine · 2019
- 0.70
Zhang SQ, Ma S, Yang TS et al. · Zhen ci yan jiu = Acupuncture research · 2024
- 0.69
Wang HC, Liu NY, Zhang S et al. · Chinese journal of integrative medicine · 2020
- 0.69
Kim MG, Woo SH, Kim GW et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.69
Shao ZQ · International journal of clinical and experimental medicine · 2015
- 0.69
Adunsky A, Chesnin V, Ravona R et al. · Archives of gerontology and geriatrics · 2004
- 0.68
Riepe MW, Kohler J, Horn R · Current medical research and opinion · 2007
- 0.67
Gareri P, Castagna A, Cotroneo AM et al. · Journal of Alzheimer's disease : JAD · 2017
- 0.67
Bergman J, Brettholz I, Shneidman M et al. · Clinical neuropharmacology · 2003
- 0.66
Huang P, He XY, Xu M · Revista da Associacao Medica Brasileira (1992) · 2021
- 0.66
Mori E, Ikeda M, Nakagawa M et al. · Dementia and geriatric cognitive disorders · 2015
- 0.65
Efficacy of donepezil combined with rehabilitation training in the treatment of Alzheimer's disease
Yi Y, Deng X · Pakistan journal of medical sciences · 2025
- 0.64
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease
Pilotto A, Franceschi M, D'Onofrio G et al. · Neurology · 2009
- 0.64
An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting
Aguglia E, Onor ML, Saina M et al. · Current medical research and opinion · 2004
- 0.64
Donepezil for the treatment of behavioral disturbances in Alzheimer's disease: a 6-month open trial
Barak Y, Bodner E, Zemishlani H et al. · Archives of gerontology and geriatrics · 2001
- 0.63
Zhang X, Yu R, Wang H et al. · Experimental and therapeutic medicine · 2020
- 0.62
Amano C, Ito T, Egawa M et al. · Nephron extra · 2013
- 0.61
Bakker C, van der Aart J, Labots G et al. · Drugs in R&D · 2021
- 0.61
Tsoi KKF, Chan JYC, Leung NWY et al. · Journal of the American Medical Directors Association · 2016
- 0.61
Yang S, Fan D, Su S et al. · Zhongguo zhen jiu = Chinese acupuncture & moxibustion · 2024
- 0.61
Persson CM, Wallin AK, Levander S et al. · BMC neurology · 2009
- 0.61
Shimazu T, Hoshino E, Nakaseko M et al. · Neuropsychiatric disease and treatment · 2026
- 0.60
Cagnin A, Cester A, Costa B et al. · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2015
- 0.60
Ikeda M, Mori E, Matsuo K et al. · Alzheimer's research & therapy · 2015
- 0.59
Bartorelli L, Giraldi C, Saccardo M et al. · Current medical research and opinion · 2005
- 0.58
Ohta Y, Darwish M, Hishikawa N et al. · Geriatrics & gerontology international · 2017
- 0.56
Depression and Alzheimer's disease: symptom or comorbidity?
Moretti R, Torre P, Antonello RM et al. · American journal of Alzheimer's disease and other dementias · 2002
- 0.56
Alzheimer's disease treated with combined therapy based on nourishing marrow and reinforcing Qi
Chen S, Yao X, Liang Y et al. · Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2015
- 0.56
Okahara K, Ishida Y, Hayashi Y et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2010
- 0.52
Yajima R, Ishiguro T, Michikawa M et al. · Journal of Alzheimer's disease reports · 2026
- 0.51
Manabe Y, Ino T, Yamanaka K et al. · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2016
03case · medications75편
- 0.95
Adverse Events With Sustained-Release Donepezil in Alzheimer Disease: Relation to Body Mass Index 이 논문
Lee C, Lee K, Yu H et al. · Journal of clinical psychopharmacology · 2017
- 0.94
Extrapyramidal side effect of donepezil hydrochloride in an elderly patient: A case report
Li HC, Luo KX, Wang JS et al. · Medicine · 2020
- 0.94
Kuwahata S, Takenaka T, Motoya T et al. · Circulation reports · 2021
- 0.93
Adverse effects associated with the use of donepezil in general practice in England
Dunn NR, Pearce GL, Shakir SA · Journal of psychopharmacology (Oxford, England) · 2000
- 0.93
Donepezil decreases heart rate in elderly patients with Alzheimer's disease
Pu Z, Xu W, Lin Y et al. · International journal of clinical pharmacology and therapeutics · 2019
- 0.93
Cardiac safety of donepezil in elderly patients with Alzheimer disease
Isik AT, Yildiz GB, Bozoglu E et al. · Internal medicine (Tokyo, Japan) · 2012
- 0.93
Syncope secondary to second-degree atrioventricular block with donepezil use
Hundae A, Afzal A, Assar MD et al. · Proceedings (Baylor University. Medical Center) · 2014
- 0.92
Tanaka A, Koga S, Hiramatsu Y · Internal medicine (Tokyo, Japan) · 2009
- 0.92
Urinary incontinence: an unrecognised adverse effect with donepezil
Hashimoto M, Imamura T, Tanimukai S et al. · Lancet (London, England) · 2000
- 0.92
Yang Y, Wei S, Tian H et al. · Frontiers in pharmacology · 2024
- 0.92
Babai S, Auriche P, Le-Louet H · Therapie · 2010
- 0.92
Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil
Suleyman T, Tevfik P, Abdulkadir G et al. · Emergency medicine journal : EMJ · 2006
- 0.92
Bilateral Lower Extremity Edema During Donepezil Treatment: A Case Report
Kang K · Current drug safety · 2026
- 0.91
Bradycardia Due to Donepezil in Adults: Systematic Analysis of FDA Adverse Event Reporting System
Morris R, Luboff H, Jose RP et al. · Journal of Alzheimer's disease : JAD · 2021
- 0.91
Zeng Y, Liu B, Zhou L et al. · Expert opinion on drug safety · 2026
- 0.91
Du Y, Li J, Han F et al. · Current Alzheimer research · 2026
- 0.91
Kose E, Yamamoto T, Tate N et al. · Die Pharmazie · 2023
- 0.90
Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial
Campbell NL, Perkins AJ, Gao S et al. · Journal of the American Geriatrics Society · 2017
- 0.90
Takahashi N, Kuroda T, Yoshioka T et al. · Clinical case reports · 2026
- 0.90
Newby D, Bobba SS, Raventos B et al. · Age and ageing · 2026
- 0.90
Igeta H, Suzuki Y, Motegi T et al. · General hospital psychiatry · 2013
- 0.90
Rhinorrhea as a Result of Alzheimer's Disease Treatment: A Case Report
Bartlett D, Bear M · The Senior care pharmacist · 2019
- 0.90
Li S, Qian W, Zhang Z et al. · Frontiers in neurology · 2025
- 0.89
Cholinesterase inhibitors and sexual disinhibition in dementia: a FAERS disproportionality study
Sayion K · Naunyn-Schmiedeberg's archives of pharmacology · 2026
- 0.89
Kroger E, Mouls M, Wilchesky M et al. · The Annals of pharmacotherapy · 2015
- 0.89
Ferreira TR, Lopes LC, Bergamaschi CdC · Frontiers in pharmacology · 2020
- 0.89
Fatal aspiration pneumonia during transition from donepezil to rivastigmine
Taylor AM, Hoehns JD, Anderson DM et al. · The Annals of pharmacotherapy · 2002
- 0.89
Donepezil-induced myoclonus in a patient with Alzheimer disease
Bougea A, Gerakoulis S, Anagnostou E et al. · The Annals of pharmacotherapy · 2014
- 0.89
Development of donepezil-induced hypokalemia following treatment of cognitive impairment
Kim D, Yoon HE, Park HS et al. · Yeungnam University journal of medicine · 2021
- 0.88
Leikin JB, Braund V, DesLauris C · The American journal of emergency medicine · 2014
- 0.88
Donepezil and Memantine-Induced Second-Degree Atrioventricular Block: A Case Report
Mahadevappa M, Hussain S, Manohar S · Hospital pharmacy · 2025
- 0.88
Liu K, Yang X, Kong L · Frontiers in pharmacology · 2026
- 0.88
Donepezil-Induced Complex Multimodal Hallucinations: Two Cases and a Review of the Literature
Pozzi FE, Tremolizzo L, Ferrarese C et al. · Case reports in neurology · 2022
- 0.88
Masurkar PP, Chatterjee S, Sherer JT et al. · Drugs & aging · 2022
- 0.87
Delirium associated with donepezil in a patient with Alzheimer's disease: a case report
Mollazadeh-Moghaddam K, Jamali A, Adili-Aghdam F et al. · Iranian journal of psychiatry · 2013
- 0.87
Co-use of donepezil and hypnotics among Alzheimer's disease patients living in the community
Stahl SM, Markowitz JS, Gutterman EM et al. · The Journal of clinical psychiatry · 2003
- 0.87
Increased libido associated with donepezil treatment: a case report
Segrec N, Zaman R, Pregelj P · Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2016
- 0.86
Pariente A, Sanctussy DJR, Miremont-Salame G et al. · CNS drugs · 2010
- 0.86
Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account
· Prescrire international · 2011
- 0.86
Lesson of the month 1: Prolonged QT syndrome due to donepezil: a reversible cause of falls?
Jackson EG, Stowe S · Clinical medicine (London, England) · 2019
- 0.86
Donepezil Treatment for Alzheimer's Disease in Chronic Dialysis Patients
Yiannopoulou KG, Anastasiou AI, Kyrozis A et al. · Case reports in nephrology and dialysis · 2019
- 0.85
Isik AT, Bozoglu E, Yay A et al. · American journal of Alzheimer's disease and other dementias · 2012
- 0.85
Otani N, Kanda K, Ngatu NR et al. · Medicina (Kaunas, Lithuania) · 2024
- 0.85
Comparative cardiovascular safety of dementia medications: a cross-national study
Fosbol EL, Peterson ED, Holm E et al. · Journal of the American Geriatrics Society · 2012
- 0.85
Comparison of cholinesterase inhibitor safety in real-world practice
Carney G, Bassett K, Wright JM et al. · Alzheimer's & dementia (New York, N. Y.) · 2019
- 0.84
Kobayashi S, Sugama N, Nagano H et al. · Drugs - real world outcomes · 2023
- 0.84
Zhang N, Gan L, Xiang G et al. · Frontiers in pharmacology · 2023
- 0.84
Effects of Cholinesterase Inhibitor Medication on QTc Interval in Memory Clinic Patients
Isotalo HK, Lehtovaara JK, Ekblad LL et al. · The Annals of pharmacotherapy · 2026
- 0.83
Upper gastrointestinal bleed associated with cholinesterase inhibitor use
Kok KS, Loke Y, Southgate J · BMJ case reports · 2015
- 0.82
Case report: Post-traumatic memories triggered by donepezil in a dose-dependent pattern
Wolff ML · The American journal of geriatric pharmacotherapy · 2012
- 0.82
Prolonged QT interval, syncope, and delirium with galantamine
Fisher AA, Davis MW · The Annals of pharmacotherapy · 2008
- 0.81
Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
Ovejero-Benito MC, Ochoa D, Enrique-Benedito T et al. · Journal of personalized medicine · 2022
- 0.80
Donepezil overdose: a tenfold dosing error
Shepherd G, Klein-Schwartz W, Edwards R · The Annals of pharmacotherapy · 1999
- 0.79
Clinical practice with antidementia drugs in a geriatric clinic
Rungsanpanya T, Muangpaisan W, Praditsuwan R · Journal of the Medical Association of Thailand = Chotmaihet thangphaet · 2012
- 0.79
Discontinuation of donepezil for the treatment of Alzheimer's disease in geriatric practice
Umegaki H, Itoh A, Suzuki Y et al. · International psychogeriatrics · 2008
- 0.77
Association of cognitive enhancers and incident seizure risk in dementia: a population-based study
Ha J, Son NH, Park YH et al. · BMC geriatrics · 2022
- 0.76
Aksoyalp ZS, Nemutlu-Samur D · International journal of geriatric psychiatry · 2024
- 0.74
Mican LM, Schulenberg S · The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2014
- 0.72
Withdrawal syndrome after donepezil cessation in a patient with dementia
Bidzan L, Bidzan M · Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2012
- 0.72
Poisoning Exposures in People with Dementia (2014‒2019): A Retrospective Study
Wojt IR, Cairns R, Tan ECK · Journal of the American Medical Directors Association · 2021
- 0.70
Neuroleptic malignant syndrome variant in a patient receiving donepezil and olanzapine
Warwick TC, Moningi V, Jami P et al. · Nature clinical practice. Neurology · 2008
- 0.70
Donepezil induces ventricular arrhythmias by delayed repolarisation
Kho J, Ioannou A, Mandal AKJ et al. · Naunyn-Schmiedeberg's archives of pharmacology · 2021
- 0.69
Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease
· Prescrire international · 2007
- 0.67
Mimura Y, Kurose S, Takata T et al. · BMC neurology · 2020
- 0.65
Cardiovascular effects of drugs used to treat Alzheimer's disease
Howes LG · Drug safety · 2014
- 0.62
Cholinergic symptoms and QTc prolongation following donepezil overdose
Pourmand A, Shay C, Redha W et al. · The American journal of emergency medicine · 2017
- 0.61
Ho BL, Liu CF, Huang YB et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.58
Drug adverse events and drop-out risk: a clinical case
Scoyni RM, Aiello L, Trani I et al. · Archives of gerontology and geriatrics · 2007
- 0.57
Odenigbo N, Nkemjika S, Atolagbe A et al. · Journal of medical case reports · 2024
- 0.57
Pharmacist-based Donepezil Outpatient Consultation Service to improve medication persistence
Watanabe N, Yamamura K, Suzuki Y et al. · Patient preference and adherence · 2012
- 0.54
Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy
Hartmann S, Mobius HJ · International clinical psychopharmacology · 2003
- 0.54
Tolerability of memantine monotherapy versus adding memantine as combination therapy
Isaac E, Ney D, Serruya M et al. · Journal of the National Medical Association · 2022
- 0.53
Marvanova M, Henkel PJ · Pharmacy (Basel, Switzerland) · 2017
- 0.51
Rissardo JP, Caprara ALF · Brain circulation · 2025
- 0.50
Donepezil-associated bradyarrhythmia in a patient with dementia with Lewy bodies (DLB)
Rosenbloom MH, Finley R, Scheinman MM et al. · Alzheimer disease and associated disorders · 2010
04cholinesterase inhibitors · galantamine19편
- 0.85
Christensen DD · Postgraduate medicine · 2012
- 0.85
The safety and tolerability of donepezil in patients with Alzheimer's disease
Jackson S, Ham RJ, Wilkinson D · British journal of clinical pharmacology · 2004
- 0.81
Donepezil in severe Alzheimer's disease
Winblad B · American journal of Alzheimer's disease and other dementias · 2009
- 0.79
Relative tolerability of Alzheimer's disease treatments
Alva G, Cummings JL · Psychiatry (Edgmont (Pa. : Township)) · 2008
- 0.74
Toxicological Differences Between NMDA Receptor Antagonists and Cholinesterase Inhibitors
Shi X, Lin X, Hu R et al. · American journal of Alzheimer's disease and other dementias · 2016
- 0.65
Deardorff WJ, Grossberg GT · Drug design, development and therapy · 2016
- 0.64
Owen RT · Drugs of today (Barcelona, Spain : 1998) · 2016
- 0.61
Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation
Mohammad D, Chan P, Bradley J et al. · Expert opinion on drug safety · 2017
- 0.59
Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics
Cacabelos R · Neuropsychiatric disease and treatment · 2007
- 0.58
Cummings JL, Geldmacher D, Farlow M et al. · CNS neuroscience & therapeutics · 2013
- 0.57
Berk C, Sabbagh M · International journal of Alzheimer's disease · 2012
- 0.56
Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil
Periclou AP, Ventura D, Sherman T et al. · The Annals of pharmacotherapy · 2004
- 0.54
· · 1994
- 0.54
Clinical profile of donepezil in the treatment of Alzheimer's disease
Doody RS · Gerontology · 1999
- 0.54
Dantoine T, Auriacombe S, Sarazin M et al. · International journal of clinical practice · 2006
- 0.54
Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease
Imbimbo BP · CNS drugs · 2001
- 0.53
An evaluation of memantine ER + donepezil for the treatment of Alzheimer's disease
Calhoun A, King C, Khoury R et al. · Expert opinion on pharmacotherapy · 2018
- 0.53
Donepezil for Alzheimer's disease: pharmacodynamic, pharmacokinetic, and clinical profiles
Shigeta M, Homma A · CNS drug reviews · 2001
- 0.51
Nordberg A, Svensson AL · Drug safety · 1998
05delivery · oral16편
- 0.93
Nakamura Y, Narita K, Kim R et al. · Journal of Alzheimer's disease : JAD · 2023
- 0.92
Nakamura Y, Omori T, Kim R et al. · Journal of Alzheimer's disease : JAD · 2023
- 0.84
Switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's disease
Sadowsky CH, Dengiz A, Olin JT et al. · American journal of Alzheimer's disease and other dementias · 2009
- 0.80
Tariot PN, Braeckman R, Oh C · Journal of Alzheimer's disease : JAD · 2022
- 0.79
- 0.78
Lee KJ, Cho SJ, Kim BC et al. · Advances in therapy · 2017
- 0.76
Choi M, Jin BH, Keum DH et al. · Clinical pharmacology in drug development · 2025
- 0.76
Suwata J, Kamata K, Nishijima T et al. · Nephron · 2002
- 0.75
Park YC, Seol E, Lee J et al. · Pharmaceutics · 2025
- 0.68
Lai TH, Wang WF, Yip BS et al. · Patient preference and adherence · 2016
- 0.68
Braeckman R, Oh C · Neurodegenerative disease management · 2023
- 0.67
Kim KA, Lim JL, Kim C et al. · Clinical therapeutics · 2011
- 0.62
Boinpally R, Chen L, Zukin SR et al. · Clinical drug investigation · 2015
- 0.61
Donepezil dosing strategies: pharmacokinetic considerations
Gomolin IH, Smith C, Jeitner TM · Journal of the American Medical Directors Association · 2011
- 0.60
Wang G, Duan X, Ouyang D et al. · Asian journal of pharmaceutical sciences · 2026
- 0.50
Ueda K, Katayama S, Arai T et al. · Dementia and geriatric cognitive disorders extra · 2019
06trials · systematic review15편
- 0.92
Proarrhythmic major adverse cardiac events with donepezil: A systematic review with meta-analysis
Nham T, Garcia MC, Tsang KLJ et al. · Journal of the American Geriatrics Society · 2024
- 0.89
Wang H, Zong Y, Han Y et al. · Expert opinion on drug safety · 2022
- 0.66
Chen Y, Lai M, Tao M · Medicine · 2024
- 0.66
Bittner N, Funk CSM, Schmidt A et al. · Drugs & aging · 2023
- 0.62
Donepezil for mild cognitive impairment
Birks J, Flicker L · The Cochrane database of systematic reviews · 2006
- 0.61
Donepezil for dementia in people with Down syndrome
Mohan M, Carpenter PK, Bennett C · The Cochrane database of systematic reviews · 2009
- 0.60
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis
Lanctot KL, Herrmann N, Yau KK et al. · CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2003
- 0.60
Kobayashi H, Ohnishi T, Nakagawa R et al. · International journal of geriatric psychiatry · 2016
- 0.60
Blanco-Silvente L, Castells X, Garre-Olmo J et al. · European journal of clinical pharmacology · 2019
- 0.59
Tan CC, Yu JT, Wang HF et al. · Journal of Alzheimer's disease : JAD · 2014
- 0.56
Amanzio M, Benedetti F, Vase L · International psychogeriatrics · 2012
- 0.55
Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis
Chen Yd, Zhang J, Wang Y et al. · European neurology · 2016
- 0.55
Battle CE, Abdul-Rahim AH, Shenkin SD et al. · The Cochrane database of systematic reviews · 2021
- 0.53
Lockhart IA, Mitchell SA, Kelly S · Dementia and geriatric cognitive disorders · 2009
- 0.52
07induced · model4편
- 0.63
Preventing Donepezil-Induced Adverse Effects Through N-acetylcysteine Co-Administration
Park J, Oh JP, Ku K et al. · Journal of Alzheimer's disease : JAD · 2024
- 0.60
Redman RR, Mackenzie H, Dissanayake KN et al. · British journal of pharmacology · 2022
- 0.55
Baakman AC, Alvarez-Jimenez R, Loewen G et al. · Alzheimer's & dementia (New York, N. Y.) · 2019
- 0.54
Voglein J, Willem M, Trambauer J et al. · Neurobiology of aging · 2019
08compounds · ache1편
- 0.51
Lumacaftor and fexofenadine prevent donepezil-induced LQTS via PHE656-mediated hERG chaperoning
Li Y, Li X, Ren J et al. · Biochemical pharmacology · 2026